Laboratory-acquired gonococcal conjunctivitis: successful treatment with single-dose ceftriaxone.
Gonococcal conjunctivitis can be a severe disease with sequelae of corneal ulceration, hypopyon, and global perforation. Current recommended therapy is hospitalization and repeated courses of parenteral antibiotics. The authors report a case successfully managed with a single injection of the new third-generation cephalosporin, ceftriaxone.
D000328:Adult; D002439:Cefotaxime / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002443:Ceftriaxone; D003231:Conjunctivitis / Q000188:drug therapy* / Q000382:microbiology; D005260:Female; D006069:Gonorrhea / Q000188:drug therapy*; D006801:Humans; D007757:Laboratory Infection / Q000188:drug therapy* / Q000382:microbiology
D002443:Ceftriaxone; D002439:Cefotaxime